Sequential Use of Hyperbaric Oxygen, Synthetic Skin Substitute and Skin Grafting in the Treatment of a Refractory Vasculitic Ulcer

Gökhan Akcali, MD,^a Günalp Uzun, MD,^a,∗ Abdül Kerim Yapici, MD,^b and  Şenol Yildiz, MD^a

Abstract

“Cutaneous leukocytoclastic vasculitis (CLCV) is a disorder characterized by the inflammation of the small vessels of the skin. CLCV may cause recurrent, drug-resistant, non-healing ulcers. Herein, we present a patient with a recalcitrant ulcer caused by CLCV, who was successfully treated with hyperbaric oxygen therapy and skin grafting. There is not any particular therapy/product that will heal all type of wounds. We can achieve better results provided that wound care products and advanced treatments are used at the right time.”

For Full Text in the archived Journal of the American College of Clinical Wound Specialists: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4495753/